When the Rally for Medical Research took place in Washington, D.C., in September, among the voices were several Endocrine Society members. We spoke to Lindsey Trevino, PhD, T. Rajendra Kumar, PhD, Heather Patisaul, PhD, and Benson Akingbemi, PhD, about why they feel so strongly about becoming “endocrine advocates.” In September, the Endocrine Society was a...
With just a day left until government funding would run out, Congress passed another temporary spending bill, but left final fiscal year (FY) 2018 funding decisions in limbo. After days of wrangling votes and changing plans, the U.S. House of Representatives and Senate passed a continuing resolution that will fund the government through January 19,...
The European Commission announced on December 13 that the Standing Committee for Plant, Animals, Food and Feed endorsed revised criteria for the identification of endocrine-disrupting chemicals (EDCs) in plant protection products. The revised criteria remove an exemption for certain pesticides designed to interfere with the endocrine systems of target organisms, taking into account the views...
Tax reform legislation (H.R. 1) approved by the U.S. House of Representatives will increase tax liability for thousands of graduate students who serve as teaching or research assistants. Under the House-passed legislation, tuition waivers granted to graduate students would be considered taxable income. More than half (55%) of all master’s and PhD candidates who serve...
Given the dramatic increases in the cost of insulin over the past decade, the Endocrine Society has been focusing on ways to address patient access to this lifesaving therapy for patients with diabetes. Our members continue to express great concern about the impact that rising insulin costs have on their patients’ diabetes treatment, as well...
On September 14, members of the Endocrine Society joined over 400 research advocates in Washington, D.C., to visit members of Congress and call for increased funding for biomedical research as part of the Rally for Medical Research. Endocrine Society members Heather Patisaul, PhD, Benson Tokunbo Akingbemi, PhD, DVM, T. Rajendra Kumar, PhD, MSC, and Lindsey...
On September 14, the Endocrine Society hosted a briefing on Capitol Hill titled “Diabetes in America: Research Accomplishments and Clinical Challenges,” sponsored by Rep. Buddy Carter (R-GA). The briefing featured presentations from Judith Fradkin, MD, of the National Institutes of Health, who shared accomplishments in diabetes research; Shivani Agarwal, MD, MPH, of the University of...
On Sept. 12, Endocrine Society members Rob Lash, MD, and David Aron, MD, took part in a public workshop devoted to hypoglycemia in older adults sponsored by the U.S. Food and Drug Administration (FDA). Aron was part of a panel that discussed current hypoglycemia medication safety efforts. Lash, chair of the Society’s Clinical Affairs Core...
Not all topics of relevance to endocrinologists are about specific conditions and diseases. Sometimes, doctors need information about changes in the medical field or the field of endocrinology. Changes to medical insurance legislation, drug trial regulations and even patient privacy legislation all impact a practitioner’s way of doing business and practicing medicine. Yet keeping track of these details is not always easy. That’s why Endocrine News has organized articles and news pieces on these topics into this advocacy page. Here, practitioners can find the information gathered by the Endocrine Society, a leading endocrinology advocacy organization, conveniently in one location.
Important Advocacy Information From the Endocrine Society
As an endocrinology advocacy organization, the Endocrine Society is constantly working to advocate for endocrinologists and their patients, both in the government and in various research centers across the country. Here on Endocrine News, you can stay informed about these efforts and their results, so you are well aware of what changes may be coming that affect your practice. This is an invaluable resource for doctors who wish to spend their time focusing on their patients, rather than advocating for their practices, but also wish to stay informed about what is happening in the field.
Both Clinical and Research Advocacy Information
On the Advocacy page, Endocrine News provides advocacy information relevant to both those in the research field and those practicing on a clinical level. Stay up to date with the activities of the Endocrine Society, learn more about the legislation that affects your work, and see highlights of leading researchers who are pioneering not only advances in the practice but also advocacy for endocrinology as a field. By utilizing the resources on the Advocacy page, you will be better equipped to meet the needs of your patients while staying abreast on the changes affecting the industry.
When the Rally for Medical Research took place in Washington, D.C., in September, among the voices were several Endocrine Society members. We spoke to Lindsey Trevino, PhD, T. Rajendra Kumar, PhD, Heather Patisaul, PhD, and Benson Akingbemi, PhD, about why they feel so strongly about becoming “endocrine advocates.” In September, the Endocrine Society was a...
On September 14, the Endocrine Society hosted a briefing on Capitol Hill titled “Diabetes in America: Research Accomplishments and Clinical Challenges,” sponsored by Rep. Buddy Carter (R-GA). The briefing featured presentations from Judith Fradkin, MD, of the National Institutes of Health, who shared accomplishments in diabetes research; Shivani Agarwal, MD, MPH, of the University of...
